The Palantir Puzzle: A Price Too High for Growth?

The market’s rollercoaster ride this year has left many investors shaken. Among those who have fallen from their highs is Palantir Technologies, which has plummeted 41% and dipped below $125. While the company’s impressive growth and surging profits are undeniable, the question on everyone’s mind is: should you buy in at these cheaper levels?

The temptation to jump into a stock that has seen such significant declines can be alluring. Palantir’s AI software analytics platform continues to grow its business at an impressive clip, with solid margin expansion. However, before making any investment decisions, consider the company’s valuation. As of writing, Palantir shares trade at a price-to-sales ratio of 60, significantly above the S&P 500 index average of 3.5. The price-to-earnings ratio (P/E) is also elevated at 138, compared to the index’s average of around 22.

This premium valuation is a result of investors’ expectations for further growth. We’ve seen this phenomenon before with tech darlings like Nvidia, which saw its shares skyrocket after its 2009 earnings report. Fast forward to today, and the same “Total Conviction” signal that flashed for Nvidia back then is now flashing for Palantir – albeit at a much smaller scale.

The Double-Edged Sword of Growth

Palantir’s growth has been nothing short of remarkable. Its revenue skyrocketed 85% year-over-year to $1.6 billion last quarter, with a staggering 104% growth in the United States. This makes it one of the most profitable software providers in the world, with a GAAP operating income of $754 million and a profit margin of 46%. However, as impressive as these numbers are, they also contribute to the company’s premium valuation.

Investors will be keeping a close eye on Palantir’s upcoming earnings report, due out on Monday, August 3. Consensus estimates are calling for 80% year-over-year revenue growth – a testament to the market’s enduring optimism about the company’s prospects. However, this optimism might also perpetuate the notion that Palantir is still a premium investment.

The Risk of Overvaluation

Some investors may see the current valuation as a buying opportunity, but others view it as a warning sign. Shareholder dilution is already a concern, with shares outstanding up 20% in the last five years and likely to continue growing at a similar rate. This could further erode investor returns, making the stock less attractive.

Moreover, the market’s tendency to overvalue growth companies has led to painful corrections in the past. Investors who bought into Nvidia in 2009 were left reeling after its shares plummeted following the company’s disappointing earnings report. History may not repeat itself, but it does rhyme – and the current market environment bears some striking similarities to that of a decade ago.

A Price Too High for Growth?

While Palantir’s growth prospects are undoubtedly compelling, its valuation is still firmly in premium territory. With significant expectations of further growth embedded in the stock price, investors may be better off waiting on the sidelines rather than jumping into the fray. As the saying goes, “the market can remain irrational longer than you can remain solvent” – and it’s precisely this unpredictability that makes investing in growth stocks so perilous.

In the end, the decision to buy Palantir stock at these levels is a personal one. But for those who value prudence over optimism, the current price might be too high to justify the risk. As investors, we must remain vigilant and not get caught up in the market’s relentless pursuit of growth – lest we forget the old adage that “greed is good” but only until it becomes “bad”.